Cart
sales@molnova.com
Icenticaftor
CAS No. 1334546-77-8
Icenticaftor( QBW251 )
Catalog No. M28717 CAS No. 1334546-77-8
Icenticaftor is an orally active potentiator of CFTR channel.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 261 | In Stock |
|
| 5MG | 330 | In Stock |
|
| 10MG | 495 | In Stock |
|
| 25MG | 791 | In Stock |
|
| 50MG | 1088 | In Stock |
|
| 100MG | 1544 | In Stock |
|
| 200MG | 2093 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIcenticaftor
-
NoteResearch use only, not for human use.
-
Brief DescriptionIcenticaftor is an orally active potentiator of CFTR channel.
-
DescriptionIcenticaftor is an orally active potentiator of CFTR channel.
-
In VitroIcenticaftor (QBW251), an orally bioavailable small molecule CFTR potentiator, can restore CFTR function in specific CFTR genotypes as well as wild-type CFTR.
-
In VivoIn Sprague-Dawley rats, the pharmacokinetic profile of Icenticaftor isestablished. After oral administration at a dose of 3 mg/kg, the oral bioavailability is 90%, and AUClast is 20?635 nmol/L?h.
-
SynonymsQBW251
-
PathwayApoptosis
-
TargetCFTR
-
RecptorHCV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1334546-77-8
-
Formula Weight361.244
-
Molecular FormulaC12H13F6N3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 150 mg/mL (415.24 mM)
-
SMILESCOc1nc(C(=O)NC[C@](C)(O)C(F)(F)F)c(N)cc1C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wahyuni, T.S., Widyawaruyanti, A., Lusida, M.I., et al.Inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from Ruta angustifolia leaves.Fitoterapia.99276-283(2014)
molnova catalog
related products
-
OSSK-674842
A novel potent CFTR potentiator that blocks hCFTR with apparent Kd of 71.3 uM; potentially serves as lead compound for development of new drugs for the treatment of cystic fibrosis.
-
Corr4A
A small molecule corrector of ΔF508-CFTR with IC50 of 6.0 uM.
-
IOWH-032
A novel and potent CFTR inhibitor (IC50=1.01 uM) in T84 and CHO-CFTR cell based assays for the treatment of cystic fibrosis; potentially serves as lead compound for development of new drugs for the treatment of cystic fibrosis.
